Dr. Deepta Bhattacharya with the University of Arizona says the most important data on that front, is still to come. He says when we are looking at the effectiveness of the vaccine, some of the fastest data we can get is on the neutralizing antibodies which is what this new study from Pfizer focuses on.
Related